亚洲 · 区域市场 · Yicai Global
Germany's Drug Price Reform Brings New Opportunities and Challenges to Chinese Drugmakers as Global Peers Reassess Investment
Roche has temporarily put all future investment decisions in Germany on hold due to local healthcare cost-cutting policies, Daniel Steiner, chief executive of the Swiss…
在 Yicai Global 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.yicaiglobal.com)
